pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
aviptadil
Acute Respiratory Distress Syndrome
Adrenergic receptor alpha
$RLFTYMindMaze Therapeutics Holding SA
0 catalysts
Phase 2
avoplacel
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
$PLURPluri Inc.
0 catalysts
Phase 2
axelopran
Opioid-Induced Constipation (OIC)
Mu-type opioid receptor
Theravance Biopharma, Inc.
← prev
page 32 of 50
next →
131
Pain89
Neurology1
$TBPH
0 catalysts
Phase 2
azenosertib
azenosertib [INN]
Endometrial Cancer
$ZNTLZentalis Pharmaceuticals, Inc.
0 catalysts
Phase 2
azerutamig
azerutamig [INN]
Esophageal Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 2
bafisontamab
Bile Duct Cancer (Cholangiocarcinoma)
Epidermal growth factor receptorHepatocyte growth factor receptor
EpimAb Biotherapeutics Inc
0 catalysts
Phase 2
balstilimab
Metastatic Colorectal Cancer
Programmed cell death protein 1
$AGENAGENUS INC
0 catalysts
Phase 2
batoclimab
batoclimab [INN]
Graves Diseases
$IMVTImmunovant, Inc.
0 catalysts
Phase 2
bedoradrine sulfate
Asthma
Beta-2 adrenergic receptor
$MNOVMEDICINOVA INC
0 catalysts
Phase 2
befiradol
befiradol [INN]
Drug-Induced Dyskinesia
Neurolixis Inc
0 catalysts
Phase 2
belacabnagene franleucel
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis)
$NKTXNkarta, Inc.
0 catalysts
Phase 2
bemcentinib
Non-Small Cell Lung Cancer
Tyrosine-protein kinase receptor UFO
Oncoinvent ASA
0 catalysts
Phase 2
bempikibart
Alopecia Areata
$QTTBQ32 Bio Inc.
0 catalysts
Phase 2
benserazide hydrochloride
Beta Thalassaemia
Aromatic-L-amino-acid decarboxylase
Phoenicia Biosciences Inc
0 catalysts
Phase 2
benzalkonium chloride + polyhexanide
benzalkonium chloride [INN] + polyhexanide [INN]
Onychomycosis (Tinea Unguium)
$TTRXTurn Therapeutics Inc.
0 catalysts
Phase 2
beperminogene perplasmid
Collategene (beperminogene perplasmid [INN])
Arteriosclerosis
AnGes Inc
0 catalysts
Phase 2
bepranemab
Alzheimer's Disease
Microtubule-associated protein tau
UCB SA
0 catalysts
Phase 2
berberine ursodeoxycholate
Primary Sclerosing Cholangitis
HighTide Therapeutics Inc
0 catalysts
Phase 2
beroterkib
Solid Tumor
$MOSMOSAIC CO
0 catalysts
Phase 2
bersiporocin
Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical Co Ltd
0 catalysts
Phase 2
betahistine dihydrochloride
Vertigo
$CYTOFAltamira Therapeutics Ltd.
0 catalysts
Phase 2
betamethasone
Keratoconjunctivitis Sicca (Dry Eye)
Glucocorticoid receptor
Surface Ophthalmics Inc
0 catalysts
Phase 2
bexmarilimab
Clevegen (bexmarilimab [INN])
Refractory Acute Myeloid Leukemia
Faron Pharmaceuticals Oy
0 catalysts
Phase 2
bexotegrast
Primary Sclerosing Cholangitis
$PLRXPLIANT THERAPEUTICS, INC.
0 catalysts
Phase 2
bintrafusp alfa
Bile Duct Cancer (Cholangiocarcinoma)
Programmed cell death 1 ligand 1Transforming growth factor beta
Merck KGaA
0 catalysts
Phase 2
birelentinib
Refractory Chronic Lymphocytic Leukemia (CLL)
Dizal Pharmaceutical Co Ltd
0 catalysts
Phase 2
bisantrene
Zantrene (bisantrene)
Refractory Acute Myeloid Leukemia
Alpha-ketoglutarate-dependent dioxygenase FTO
Racura Oncology Ltd
0 catalysts
Phase 2
bitopertin
Anemia
Sodium- and chloride-dependent glycine transporter 1
$IRONDisc Medicine, Inc.
0 catalysts
Phase 2
bivamelagon
bivamelagon [INN]
Obesity
$RYTMRHYTHM PHARMACEUTICALS, INC.
0 catalysts
Phase 2
bizaxofusp
bizaxofusp [INN]
Recurrent Glioblastoma Multiforme (GBM)
$MDNAFMedicenna Therapeutics Corp.
0 catalysts